GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (LTS:0LG9) » Definitions » Cyclically Adjusted FCF per Share

Asensus Surgical (LTS:0LG9) Cyclically Adjusted FCF per Share : $0.00 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Asensus Surgical Cyclically Adjusted FCF per Share?

Note: As Cyclically Adjusted FCF per Share is a main component used to calculate Cyclically Adjusted Price-to-FCF. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Asensus Surgical's adjusted free cash flow per share for the three months ended in Mar. 2024 was $-0.060. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 47.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 28.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Asensus Surgical was 86.30% per year. The lowest was -397.70% per year. And the median was 0.20% per year.

As of today (2024-06-10), Asensus Surgical's current stock price is $3.07177. Asensus Surgical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.00. Asensus Surgical's Cyclically Adjusted Price-to-FCF of today is .


Asensus Surgical Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Asensus Surgical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical Cyclically Adjusted FCF per Share Chart

Asensus Surgical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -65.22 -147.64 - - -

Asensus Surgical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Asensus Surgical's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Asensus Surgical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asensus Surgical's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Asensus Surgical's Cyclically Adjusted Price-to-FCF falls into.



Asensus Surgical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Asensus Surgical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.06/131.7762*131.7762
=-0.060

Current CPI (Mar. 2024) = 131.7762.

Asensus Surgical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -1.661 100.560 -2.177
201409 -2.384 100.428 -3.128
201412 -1.993 99.070 -2.651
201503 -1.707 99.621 -2.258
201506 -1.540 100.684 -2.016
201509 -1.339 100.392 -1.758
201512 -1.903 99.792 -2.513
201603 -1.873 100.470 -2.457
201606 -1.482 101.688 -1.921
201609 -1.141 101.861 -1.476
201612 -1.761 101.863 -2.278
201703 -1.544 102.862 -1.978
201706 -1.263 103.349 -1.610
201709 -1.056 104.136 -1.336
201712 -0.669 104.011 -0.848
201803 -0.814 105.290 -1.019
201806 -0.447 106.317 -0.554
201809 -1.031 106.507 -1.276
201812 -0.793 105.998 -0.986
201903 -1.458 107.251 -1.791
201906 -0.917 108.070 -1.118
201909 -1.115 108.329 -1.356
201912 -0.724 108.420 -0.880
202003 -0.432 108.902 -0.523
202006 -0.242 108.767 -0.293
202009 -0.090 109.815 -0.108
202012 -0.123 109.897 -0.147
202103 -0.052 111.754 -0.061
202106 -0.037 114.631 -0.043
202109 -0.039 115.734 -0.044
202112 -0.058 117.630 -0.065
202203 -0.069 121.301 -0.075
202206 -0.062 125.017 -0.065
202209 -0.064 125.227 -0.067
202212 -0.062 125.222 -0.065
202303 -0.074 127.348 -0.077
202306 -0.077 128.729 -0.079
202309 -0.066 129.860 -0.067
202312 -0.057 129.419 -0.058
202403 -0.060 131.776 -0.060

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Asensus Surgical  (LTS:0LG9) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Asensus Surgical Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Asensus Surgical (LTS:0LG9) Business Description

Traded in Other Exchanges
Address
1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical (LTS:0LG9) Headlines

No Headlines